AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND

Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.